Therini Bio, Inc.
Clinical trials sponsored by Therini Bio, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New Alzheimer's drug THN391 enters first patient trial Results expected Mar 2027 (estimated)